While adenovirus-mediated overexpression of human HSD17B13 in mice has been linked to elevated hepatic lipid levels (Su et al, 2014), its genetic deletion has also been associated with exacerbated liver steatosis or macro-vesicular steatosis (Adam et al, 2018; Ma et al, 2021). Here, HSD17B13 is linked to fatty liver disease.